My Breast Cancer came back — what are my options now

Your Breast Cancer Recurrence: Understanding Your Options

I'm sorry you're facing a recurrence. This is understandably difficult, but there are meaningful treatment options available. Let me help you understand what doctors typically consider and what questions to ask your care team.

How Doctors Approach Recurrent Breast Cancer

According to the NCCN Guidelines for Patients: Metastatic Breast Cancer, when breast cancer returns, your oncology team will take a systematic approach:

1. Confirm the recurrence through imaging and possibly biopsy
2. Re-test your tumor for hormone receptors (ER/PR) and HER2 status, since these can change
3. Look for new mutations that may have developed, which could open up targeted therapy options
4. Assess your overall health to determine what treatments your body can tolerate

Key Testing You May Need

Your doctors will likely recommend:

• Imaging studies (CT, PET scans) to see where the cancer has returned
• Blood tests including tumor markers
• Biomarker testing on new tumor tissue to identify actionable mutations like:
  • PIK3CA, AKT1, PTEN mutations
  • ESR1 mutations (in hormone receptor-positive cancers)
  • BRCA1/2 status (if not already tested)
  • Other mutations that respond to targeted therapies

According to the NCCN Guidelines, certain mutations can be targeted with specific therapies, which may offer better outcomes than standard chemotherapy alone.

General Treatment Approaches That Exist

For Hormone Receptor-Positive (HR+) Cancers:

• Endocrine therapy (hormone-blocking medications) often combined with CDK4/6 inhibitors
• Newer options like selective estrogen receptor degraders (SERDs)
• Chemotherapy if hormone therapy is no longer effective

For HER2-Positive Cancers:

• Targeted therapies like Herceptin (trastuzumab) and newer HER2-directed agents
• Often combined with chemotherapy or other targeted drugs

For Triple-Negative Cancers:

• Chemotherapy remains a primary option
• Immunotherapy approaches
• PARP inhibitors (if BRCA mutations present)

Across All Types:

• Clinical trials testing newer combinations
• Circulating tumor DNA (liquid biopsy) tests like Signatera to monitor treatment response

Real-World Perspective

From the CancerPatientLab webinar "An MD PhD Navigates Breast Cancer," Dr. [removed] Lopez-Correa shares that when facing recurrence, patients benefit from:

• Comprehensive genomic testing to identify new treatment options
• Understanding that test results can guide both treatment decisions AND monitoring strategies
• Recognizing that some tests help increase vigilance with imaging rather than immediately changing treatment

Critical Questions to Ask Your Oncologist

1. About your specific situation:

   • Where has the cancer returned (local, distant, or both)?
   • Has the hormone receptor or HER2 status changed since my original diagnosis?
   • What biomarker testing do you recommend, and why?

2. About treatment options:

   • Based on my tumor's characteristics, what are the treatment options you recommend?
   • Are there clinical trials appropriate for my specific cancer profile?
   • What is the goal of treatment—to shrink the tumor, control growth, or manage symptoms?

3. About testing:

   • Should I get comprehensive genomic profiling of my recurrent tumor?
   • Are there liquid biopsy tests (circulating tumor DNA) that could help monitor my response?
   • Will these tests change your treatment recommendations?

4. About side effects and quality of life:

   • What side effects should I expect with each option?
   • How will we monitor whether treatment is working?
   • Under what circumstances would you change treatment if the current approach isn't effective?

5. About second opinions:

   • Would you support me getting a second opinion from another oncologist?
   • Are there cancer centers with particular expertise in my type of recurrence?

Important Perspective on Genetic Testing

If you haven't had germline (inherited) genetic testing, the NCCN Guidelines recommend it for all patients with metastatic breast cancer. This is important because:

• It identifies if you carry BRCA1/2 mutations, which opens specific treatment options
• It has implications for your family members
• It may qualify you for targeted therapies

Moving Forward

According to CancerPatientLab resources on self-advocacy, patients benefit from:

• Getting copies of all test results and pathology reports
• Bringing a support person to appointments
• Writing down questions beforehand
• Taking notes during visits
• Asking your care team to explain results thoroughly

Your oncologist will determine the most appropriate approach for YOUR specific case based on:

• Where the cancer has returned
• Your tumor's molecular characteristics
• Your overall health and performance status
• Your preferences and goals for treatment

This is a time to be actively engaged with your care team. Don't hesitate to ask questions, request testing, or seek a second opinion.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.